Fig. 4From: Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysisThe PFS (A) and OS (B) curves for 31 cases with AFTV immunotherapy (left) and each curve of the cases divided by EOR consisting of GTR, STR, and PR (right). The log-rank test was used for analysisBack to article page